Stock GLYC GLYCOMIMETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. GlycoMimetics, Inc.

Equities

GLYC

US38000Q1022

Real-time Estimate Cboe BZX
Other stock markets
 12:26:37 2024-06-27 EDT 		5-day change 1st Jan Change
0.291 USD -0.31% Intraday chart for GlycoMimetics, Inc. +15.04% -87.81%
06-04 Transcript : GlycoMimetics, Inc. - Special Call
06-04 GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50
MT
Capital One Initiates GlycoMimetics With Overweight Rating, Price Target is $12
MT
HC Wainwright Adjusts GlycoMimetics Price Target to $13 From $14, Maintains Buy Rating
MT
Jefferies Raises GlycoMimetics to Buy From Hold, Price Target to $4 From $3
MT
GLYCOMIMETICS : Roth Capital Adjusts GlycoMimetics' Price Target to $15 From $9, Reiterates Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLYC Stock
  4. News GlycoMimetics, Inc.
  5. Analyst Reco.